iRadimed
IRMD
$43.48
Share price
3.52%
Change (1 day)
3.62%
Change (1 year)
Categories
Earnings for iRadimed (IRMD)
Earnings in 2023 (TTM): $21.73 M
According to iRadimed's latest financial reports the company's current earnings (TTM) are $21.73 M. In 2022 the company made an earning of $16.18 M an increase over its 2021 earnings that were of $9.83 M.The earnings displayed on this page is the company's Pretax Income.
Earnings history for iRadimed from 2013 to 2023
Annual earnings
| Year | Earnings | Change |
|---|---|---|
2023 (TTM)  | $21.73 M | 34.35% |
| 2022 | $16.18 M | 64.5% |
| 2021 | $9.83 M | -1694.53% |
| 2020 | -$0.62 M | -106.82% |
| 2019 | $9.04 M | 45.92% |
| 2018 | $6.19 M | 343.81% |
| 2017 | $1.39 M | -87.25% |
| 2016 | $10.95 M | -5.86% |
| 2015 | $11.63 M | 285.59% |
| 2014 | $3.01 M | 8.39% |
| 2013 | $2.78 M |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 Edwards Lifesciences EW | $1.61 B | 7,332.50% | 🇺🇸 USA |
 NuVasive NUVA | $60.92 M | 180.26% | 🇺🇸 USA |
 DexCom DXCM | $0.79 B | 3,574.16% | 🇺🇸 USA |
 AtriCure ATRC | -$22.93 M | -205.45% | 🇺🇸 USA |